Digest Network Come funziona
Network
/
Società
Oa
Non verificato

Oak Hill Bio

Di cosa scriviamo

BiotecnologiaFarmaceuticaIndustriaMedicina - VarieSalute

5 comunicati stampa

Guarda tutti i comunicati
09/09/2025
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Industria
Oak Hill Bio Spotlights Publication Detailing Discovery and Initial Development of Rugonersen in Nucleic Acids Research
Fonte
Oak Hill Bio
Emittente
Business Wire
1.00
0
11/07/2025
Salute
Biotecnologia
Medicina - Varie
Farmaceutica
Industria
Oak Hill Bio Announces Publication of Rugonersen Phase 1 Study Results in Nature Medicine
Fonte
Oak Hill Bio
Emittente
Business Wire
1.00
0
15/04/2025
Mercato del lavoro
Industria
Salute
Igiene alimentare
Biotecnologia
Medicina - Varie
Farmaceutica
Oak Hill Bio Enters into Exclusive License Agreement with Roche to Obtain Global Rights for a Phase 3-Ready, Potential Best-in-Class Treatment for Individuals with Angelman Syndrome
Fonte
Oak Hill Bio
Emittente
Business Wire
1.00
0
04/11/2024
Industria
Igiene alimentare
Salute
Medicina - Varie
Sanità
Farmaceutica
Biotecnologia
Oak Hill Bio and Chiesi Group Announce First European Patient Enrolled in the Phase 2b Clinical Study Evaluating OHB-607 for the Prevention of Bronchopulmonary Dysplasia, the Most Common Cause of Chronic Lung Disease in Premature Infants
Fonte
Oak Hill Bio
Emittente
Business Wire
1.00
0
07/10/2024
Mercato del lavoro
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Oak Hill Bio Announces Promotion of Josh Distler to Chief Executive Officer and Additional Updates to Executive Team and Board
Fonte
Oak Hill Bio
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0